AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS)

CUSIP: 00791X118

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / *W EXP 07/21/202
Total 13F shares
4,356,029
Share change
-25,980
Total reported value
$421,526
Price per share
$0.10
Number of holders
30
Value change
-$6,404
Number of buys
3
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 00791X118?
CUSIP 00791X118 identifies AEONWS - AEON BIOPHARMA INC - *W EXP 07/21/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS) as of Q4 2023

As of 31 Dec 2023, AEON BIOPHARMA INC - *W EXP 07/21/202 (AEONWS) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,356,029 shares. The largest 10 holders included Shaolin Capital Management LLC, CANTOR FITZGERALD, L. P., DAVIDSON KEMPNER CAPITAL MANAGEMENT LP, ARISTEIA CAPITAL, L.L.C., LMR Partners LLP, COWEN AND COMPANY, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., PERISCOPE CAPITAL INC., and Radcliffe Capital Management, L.P.. This page lists 30 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.